Mark Kirchhof

Mark Kirchhof is a Clinical Professor and Head of Dermatology Division within the Department of Medicine at the University of Ottawa and The Ottawa Hospital. His primary affiliations include academic and clinical roles focused on dermatological research and patient care. He leads initiatives in inflammatory skin diseases, immunology, and cancer-related dermatology. His research spans over 15 years, with significant contributions to clinical guidelines and disease management protocols.

Research interests include immune-mediated skin disorders (e.g., hidradenitis suppurativa, psoriasis), cancer dermatology (skin toxicities in oncology), and systemic therapies. He has authored numerous studies on treatment guidelines, comorbidity management, and emerging therapeutics. His work often integrates clinical practice with public health perspectives, such as economic evaluations of dermatological interventions and cannabis-related product use analysis.

Notable contributions include leading the Canadian Pustular Psoriasis Study (CAPPS) and developing consensus guidelines for hidradenitis suppurativa management. He collaborates with multidisciplinary teams to address complex cases involving immunosuppressive therapies, toxic epidermal necrolysis, and drug-induced skin reactions.